#Bioretec #Finland #Tampere #Jordy Winters #OUS Sales

Bioretec Announces Leadership Change

On September 2, 2025, Bioretec Ltd, a leader in the development of absorbable orthopedic implants, revealed the appointment of Jordy Winters as Vice President of Sales Outside the U.S. (OUS). This strategic move aims to accelerate the company's growth in key international markets and strengthen its operational framework.

Introducing Jordy Winters

Jordy Winters brings a wealth of experience to his new position, having previously held significant roles within Johnson & Johnson MedTech and Synthes. His leadership track record includes driving regional strategies and achieving commercial milestones, particularly in his recent role as Spine Lead EMEA. With nearly 20 years of experience in the orthopedic sector, Winters has consistently demonstrated an ability to build effective teams and foster the adoption of innovative orthopedic solutions.

In his new role, Winters will shape Bioretec's international sales strategy, focusing on expanding the company’s presence across Europe and other global markets. His expertise is expected to be critical as Bioretec seeks to leverage its advanced products and technologies in a rapidly evolving landscape of orthopedic solutions.

Bioretec’s Growth Strategy

Bioretec is entering a transformative period, with an increased demand for sustainable, innovative orthopedic products. With the Activa bioabsorbable polymer platform and RemeOs absorbable magnesium alloy technology, the company is well-positioned to address various orthopedic challenges. These technologies not only enhance surgical outcomes but also minimize the need for invasive follow-up procedures.

Sarah van Hellenberg Hubar-Fisher, the CEO of Bioretec, expressed enthusiasm for Winters’ appointment, stating, “His extensive experience in global orthopedic sales leadership will be invaluable as we expand our influence in markets outside the U.S.” This sentiment outlines the company’s commitment to advancing its agenda internationally while enhancing patient outcomes.

Future Enhancements in Medical Education

In alignment with these changes, Rami Ojala, the former Vice President of OUS Sales, will transition to a newly established role as Head of Global Medical Education. Ojala’s focus will be on developing comprehensive training programs for surgeons and advancing clinical education initiatives. This is a crucial step in ensuring that Bioretec's innovations are effectively integrated into practice globally.

About Bioretec

Founded in Finland, Bioretec is revolutionizing the field of orthopedic medical devices with its groundbreaking biodegradable implant technologies. The firm specializes in creating devices that not only facilitate superior healing outcomes but are also environmentally responsible.

A highlight of their product line includes the Activa series, which features implants that are bioabsorbable and utilize a proprietary PLGA polymer for secure fixation. These implants break down naturally within two years, significantly reducing the need for additional surgeries. Furthermore, Bioretec's latest innovation, the RemeOs product line, made from a high-performance magnesium alloy, represents a significant advancement in the realm of absorbable materials, helping to ensure improved recovery rates and patient satisfaction.

As Bioretec prepares for its next chapter of growth, the company remains committed to enhancing orthopedic care through innovative solutions. For more information about Bioretec and its products, please visit Bioretec's website.